by 宏潤会 大同病院
名古屋市南区の高度急性期病院「大同病院」が、病院を利用される患者さんやそのご家族に向けて、病院の日常や、医療・介護に関するあれこれを、楽しく分かりやすくお届けしていくラジオです。 ■■■最新コンテンツはVoicyでお送りしています。 https://voicy.jp/channel/3632 ■■■大同病院・だいどうクリニック https://daidohp.or.jp/
Language
🇯🇵
Publishing Since
9/12/2023
Email Addresses
1 available
Phone Numbers
0 available
December 2, 2024
Dr. Shinohara and Ismyn discuss how HIV/AIDS patients in Nagoya, Japan, are fighting against discrimination and prejudice, highlighting the need for greater social inclusion and understanding.
December 1, 2024
Dr.シノハラ and イズミン discuss the current state of HIV/AIDS patients, who face a harsher battle against social stigma than the disease itself, with guest Dr.林雅 from 大同病院's infectious disease department.
November 30, 2024
Dr.シノハラ and Izumin discuss how people can prepare for their final days by having open conversations with loved ones and medical teams through life planning meetings, also known as '人生会議'.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.